Prickly Patch Delivery of Experimental COVID-19 Vaccine Shows Promise in Animal Study | NIH: National Institute of Allergy and Infectious Diseases

Prickly Patch Delivery of Experimental COVID-19 Vaccine Shows Promise in Animal Study | NIH: National Institute of Allergy and Infectious Diseases

Friday, April 3, 2020 Prickly Patch Delivery of Experimental COVID-19 Vaccine Shows Promise in Animal Study A candidate vaccine delivered though a thumbnail-sized patch studded with microneedles could help address the coronavirus disease 2019 (COVID-19) pandemic. NIH-funded scientists at University of Pittsburgh School of Medicine tested the vaccine delivery device in mice and published the results April 2 in The Lancet journal EBioMedicine. The NIAID Now blog has more.